Today, Explained · Podcast summary
Good news about Alzheimer’s
Investigative journalist Charles Piller and Vox reporter Dylan Scott discuss the history of Alzheimer's research, a major fraud that derailed progress, and the promising new treatments and preventative measures emerging today.
Listen on the show ↗Key takeaways
- 😨Alzheimer's disease is uniquely terrifying because it gradually causes people to lose their sense of who they are, progressing from minor memory lapses to the inability to navigate the world or recognize loved ones.00:01
- 👴For a long time, Alzheimer's was considered a medical curiosity because few people lived long enough to develop it; it only became a major problem as life expectancy increased.03:24
- 🧠The amyloid cascade hypothesis, which dominated Alzheimer's research for decades, posited that amyloid plaques in the brain were the primary cause of the disease, leading to billions of dollars in research aimed at removing them.04:31
- 🚨A seminal study supporting the amyloid hypothesis was found to have doctored scientific images, meaning one of the foundational pieces of evidence for the theory was based on false information.10:23
- 💰Tens of billions of dollars were spent chasing the amyloid hypothesis, with the majority of that investment going into amyloid-related product development and basic research, despite a lack of significant breakthroughs.11:30
- 💊Two new drugs, lecanemab and donanemab, have been approved by the FDA; they target amyloid plaques and have shown some effect in slowing cognitive decline, offering the first real hope for treatment.17:26
Chapters
- 0:00The Terrifying Nature of Alzheimer's
- 3:28The Amyloid Hypothesis and Early Research
- 10:41The Discovery of Fraud in Alzheimer's Research
- 25:42New Hope: Approved Treatments and a Broader Understanding
- 34:13Promising New Avenues: GLP-1 Drugs and Chinese Surgery
- 37:12The Holy Grail: Reversing Alzheimer's
The digest
Alzheimer's disease is a uniquely terrifying condition that gradually erodes a person's sense of self, memory, and ability to navigate the world. It's a progressive disease, starting with minor forgetfulness and advancing to the inability to recognize loved ones or even one's own home. As memories fade, so do relationships, making Alzheimer's a cruel disease that captures the very essence of a person's self. For decades, there was little hope, but recent breakthroughs offer a glimmer of good news.
The Amyloid Hypothesis and Its Flawed Foundation
For many years, the prevailing theory in Alzheimer's research was the "amyloid cascade hypothesis." This theory, which emerged in the 1970s, 80s, and 90s, posited that the accumulation of amyloid proteins in the brain, forming plaques, was the primary cause of the disease. Charles Piller, an investigative journalist, explains that the disease was initially defined by the presence of these plaques, along with tangles and dementia. In the early 1900s, when Alzheimer's was first identified by Alois Alzheimer, it was considered a rare curiosity because few people lived long enough to develop it. However, with advances in medicine leading to increased life expectancy, Alzheimer's became a major public health problem.
Billions of dollars were poured into research and drug development based on the amyloid hypothesis. Scientists believed that if they could remove these plaques from the brain, they could cure or at least slow the progression of Alzheimer's. Early trials, including a vaccine developed in the early 2000s, showed promise in efficiently removing plaques from the brain. However, these treatments failed to improve patients' symptoms or reverse the disease. In fact, some drugs had terrible and even dangerous side effects. This led to widespread discouragement and a re-evaluation of the amyloid hypothesis.
Keep reading in The Digest
The full 4-minute article, 3 more sections, and every new episode from Today, Explained and the creators you follow.
- A Shocking Discovery: Fraud in Alzheimer's Research
- Emerging Hope: New Treatments and Preventative Measures
- The Promise of GLP-1 Drugs and Chinese Surgical Breakthroughs
More from Today, Explained
The GOP strategy: Ignore Trump
Vivek Ramaswamy runs for Ohio governor amid Republican struggles with Trump’s unpopularity and midterm challenges.
Our AI Cold War
Andrew Prokop and Kyle Chan discuss the AI strategies of Donald Trump and China, revealing a complex AI cold war marked by competing visions, open source debates, and geopolitical tensions.
The end of etiquette
John Glynhill explores the decline of social etiquette with experts Kirstie Sedgman, Lizzie Post, and Tessa West, revealing how manners shape society, public spaces, and workplaces today.
Trump’s temper tantrum
Jonathan Edwards from the Washington Post explains the ongoing saga of President Trump's attempts to rename the Kennedy Center and the White House ballroom, revealing a deeper obsession with his legacy.
We should party more
Imogen "Immy" Williams, author of "Up All Night: A History of Going Out," and party host Halston Bruce explain how to throw the perfect party and why parties are so important for human connection.
Latino voters swing back
Stephanie Valencia, co-founder and president of Equis, and Manny Rutinel, Democratic congressional candidate, discuss the evolving landscape of Latino voters, challenging traditional political assumptions and highlighting the critical role of economic issues and cultural understanding in electoral success.